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of Dendritic Cells To Stimulate CD4 T
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Carol L. Pickett,a Beth A. Garvya,c
Department of Microbiology, Immunology, and Molecular Genetics,a Department of Statistics,b and Division of
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ABSTRACT The life cycle of the opportunistic fungal pathogen Pneumocystis murina
consists of a trophic stage and an ascus-like cystic stage. Infection with the cyst
stage induces proinflammatory immune responses, while trophic forms suppress the
cytokine response to multiple pathogen-associated molecular patterns (PAMPs), in-
cluding -glucan. A targeted gene expression assay was used to evaluate the den-
dritic cell response following stimulation with trophic forms alone, with a normal
mixture of trophic forms and cysts, or with -glucan. We demonstrate that stimula-
tion with trophic forms downregulated the expression of multiple genes normally
associated with the response to infection, including genes encoding transcription
factors. Trophic forms also suppressed the expression of genes related to antigen
processing and presentation, including the gene encoding the major histocompati-
bility complex (MHC) class II transactivator, CIITA. Stimulation of dendritic cells with
trophic forms, but not a mixture of trophic forms and cysts, reduced the expression
of MHC class II and the costimulatory molecule CD40 on the surface of the cells.
These defects in the expression of MHC class II and costimulatory molecules corre-
sponded with a reduced capacity for trophic form-loaded dendritic cells to stimulate
CD4 T cell proliferation and polarization. These data are consistent with the de-
layed innate and adaptive responses previously observed in immunocompetent mice
inoculated with trophic forms compared to responses in mice inoculated with a mix-
ture of trophic forms and cysts. We propose that trophic forms broadly inhibit the
ability of dendritic cells to fulfill their role as antigen-presenting cells.
KEYWORDS pneumocystis, T cells, cytokines, dendritic cells, fungal infection, lung
defense
Pneumocystis species are opportunistic fungal pathogens that cause severe pneu-monia in immunocompromised hosts, including AIDS patients and patients under-
going immunosuppressive therapies. Clearance of Pneumocystis organisms is depen-
dent on the generation of effective CD4 T cell responses (1–3). Failure to clear
Pneumocystis organisms leads to severe immune-mediated alveolar damage (4). While
improvements in antiviral therapies have reduced the incidence of Pneumocystis pneu-
monia (PcP) in HIV-infected individuals and other at-risk populations, the mortality rate
for patients with PcP has not improved (5). Additional studies are required to inform
novel approaches to reduce morbidity and mortality due to Pneumocystis pneumonia.
Pneumocystis species have a biphasic life cycle consisting of trophic forms and cysts.
Trophic forms are single-nucleated organisms typically found in clusters surrounded by
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a biofilm-like substance consisting of a conglomeration of DNA, -glucan, and other
sugars (6). Cysts are ascus-like structures that consist of multiple nuclei surrounded by
a fungal cell wall consisting of -1,3-glucan and -1,6-glucan (7–9). Trophic forms do
not express -glucan and do not form a cell wall (8).
Dendritic cells are the principal antigen-presenting cells in the lung. However, their
role in initiating the adaptive response to Pneumocystis has been understudied. Previ-
ous work has demonstrated that dendritic cells activated by Pneumocystis cell wall-
derived -glucan increase the expression of costimulatory molecules and drive Th1
polarization (10). The mechanism for dendritic cell recognition of Pneumocystis trophic
forms, which do not express -glucan, is unknown. Both stages express surface
glycoproteins and mannoproteins that may serve as pathogen-associated molecular
patterns (PAMPs) that could be recognized by receptors on host cells (7–9). Intriguingly,
neither life form expresses the classical fungal components ergosterol, chitin, or
-glucan (10, 11).
We have previously reported that the life cycle stages of Pneumocystis murina have
opposing effects on the immune response (11). The immune response to infection with
P. murina trophic forms alone was less robust than the response to infection with a
physiologically normal mixture of cysts and trophic forms. Infection with trophic forms
alone resulted in reduced numbers of CD11c innate immune cells in the lungs, as well
as reduced recruitment of activated CD4 and CD8 T cells, compared to infection with
a normal mixture of trophic forms and cysts. In vitro, trophic forms suppressed
production of the proinflammatory cytokines interleukin-1 (IL-1), IL-6, and tumor
necrosis factor alpha (TNF-) by bone marrow-derived dendritic cells (BMDCs) stimu-
lated with -glucan, zymosan, depleted zymosan, lipoteichoic acid (LTA), or lipopoly-
saccharides (LPS). In addition, trophic form-stimulated BMDCs failed to stimulate pro-
duction of the Th1-type cytokine gamma interferon (IFN-) by CD4 T cells.
Here, we demonstrate that P. murina trophic forms hinder the ability of dendritic
cells to serve in their essential role as stimulators of CD4 T cell responses by reducing
the capacity of dendritic cells to produce proinflammatory cytokines, present antigen,
and express costimulatory molecules. Treatment of dendritic cells with trophic forms
induced a less robust pattern of expression of immunity-related genes than treatment
with a mixture of P. murina trophic forms and cysts. In addition, treatment with trophic
forms reduced the ability of dendritic cells to increase surface expression of major
histocompatibility complex (MHC) class II and CD40 in response to stimulation with
mixed P. murina organisms or zymosan. These defects in the expression of MHC class
II and costimulatory molecules corresponded with a reduced capacity for trophic
form-loaded dendritic cells to stimulate CD4 T cell proliferation and polarization.
RESULTS
P. murina trophic forms induce a suppressive pattern of gene expression in
dendritic cells. Pneumocystis trophic forms suppress the production of proinflamma-
tory cytokines by dendritic cells stimulated with multiple PAMPs (11). These PAMPs are
recognized by a range of pattern recognition receptors that mediate diverse signaling
pathways within the cell, including, in the case of IL-1, inflammasome activation.
These data suggest that P. murina trophic forms have a broadly suppressive effect on
dendritic cells. To evaluate the activity of dendritic cells in response to trophic forms,
we employed a target gene expression array to analyze the dendritic cell response to
P. murina trophic forms based on the expression of 561 immunity-related mouse
transcripts (NanoString nCounter Mouse Immunology CodeSet).
The normalized data illustrate that trophic forms induced a broader pattern of
suppression in dendritic cells than stimulation with a normal mixture of cystic and
trophic forms (mixed Pneumocystis organisms) or the -glucan curdlan (Fig. 1A to D,
mixed Pc or curdlan, respectively). Curdlan is a high-molecular-weight -1,3-glucan
isolated from Alcaligenes faecalis and is homologous to the -1,3-glucan that composes
the P. murina cyst wall (7, 8). Curdlan is employed in these experiments as a reductive
positive control for -glucan-induced signaling in BMDCs. The heat map shown in
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Fig. 1A depicts the relative values of the 561 transcripts for each sample (n  5) within
each treatment group at 8 h posttreatment. Data are shown as the relative gene
expression value compared to that of the unstimulated control. A large portion of the
immunity-related genes were induced by treatment with curdlan but downregulated
by treatment with trophic forms (Fig. 1A). Stimulation with a mixture of P. murina
organisms did not induce total gene expression as robustly as treatment with the
positive control, curdlan (Fig. 1A). However, stimulation with mixed P. murina organ-
isms did lead to upregulation of a greater number of genes than stimulation with
trophic forms alone (Fig. 1A). Intriguingly, stimulation with trophic forms and mixed P.
murina organisms led to the upregulation of several genes whose expression was not
induced by curdlan (Fig. 1A and C).
Experimental data shown in Fig. 1B represent the principal-component analysis-
based clustering of the samples within each group after 8 h of treatment. Each of the
groups formed distinct clusters, indicating a unique pattern of gene expression follow-
ing each treatment. Experimental data shown in Fig. 1C and D represent genes
upregulated or downregulated in the treated groups relative to levels in the untreated
control (P  0.01). Of the 561 immunity-related transcripts, stimulation with trophic
forms induced the statistically significant upregulation of 154 genes (Fig. 1C) and the
downregulation of 130 genes (Fig. 1D) relative to the levels in the unstimulated control.
A total of 121/154 (78.6%) of the genes upregulated (Fig. 1C) by stimulation with
trophic forms and 93/130 (71.5%) of the genes downregulated (Fig. 1D) by treatment
with trophic forms were also upregulated or downregulated (respectively) in the mixed
P. murina- and curdlan-treated groups. The pattern of gene expression in response to
mixed P. murina organisms (a mixture of 10 trophic forms to one -glucan-expressing
cyst) was similar to the phenotypes induced by either trophic forms or curdlan, with
few unique genes either up- or downregulated (Fig. 1C and D). The data shown in Fig.
1 demonstrate that trophic forms induce a unique pattern of gene expression in regard
FIG 1 Exposure of BMDCs to P. murina trophic forms induces a distinct pattern of gene expression. A total
of 3  105 BMDCs from adult BALB/cJ mice were incubated with 1.5  106 trophic forms or 1.5  106 mixed
P. murina organisms (mixed Pc). Controls included untreated BMDCs and BMDCs treated with 10 g/ml of
the -glucan curdlan. Cells were lysed after 2, 4, or 8 h of incubation. RNA was extracted. Gene expression
analysis was carried out using a preassembled NanoString CodeSet that measures expression of 561
immunity-related mouse transcripts (nCounter Mouse Immunology kit). Analysis and normalization of the
raw NanoString data were conducted using nSolver Analysis Software, version 2.0. Raw counts were
normalized to those of the internal positive controls and reference transcripts. A heat map (A) was
generated to display the expression value in treated cells relative to that in untreated cells. Principal-
component (PC) analysis (B) was used to compare the patterns of gene expression among the untreated
and treated groups following 8 h of incubation. Genes upregulated (C) or downregulated (D) in the treated
groups relative to levels in the untreated control were identified by log-transformed two-way ANOVA,
followed by pairwise comparisons using the least significant difference method. Five biological replicates
were used per group. A change was deemed significant if the P value was 0.01.
Dendritic Cell Suppression by P. murina Trophic Forms Infection and Immunity
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to both the identity of the gene transcript and the magnitude of the change in
expression. In contrast, treatment with mixed P. murina organisms induces a pattern of
gene expression that represents an intermediate phenotype between the compara-
tively suppressive pattern of gene expression that is induced by trophic forms and the
highly inflammatory pattern that is induced by the -glucan curdlan.
Trophic forms induce the expression of genes encoding chemokines and
complement proteins. As shown in Fig. 1C, stimulation with trophic forms induced the
statistically significant upregulation of 154 genes compared to the levels in the un-
stimulated control. The data in Fig. S1A in the supplemental material represent genes
in the NanoString panel with a statistically significant (P  0.01) 4-fold or greater
increase in expression in BMDCs treated with trophic forms compared to the level in
unstimulated BMDCs. Several genes on this list are related to the complement system
or encode chemokines. Notably, many of these genes, including the genes encoding
complement system transcripts, are more highly expressed in cells treated with trophic
forms than in cells stimulated with curdlan or a mixture of P. murina organisms.
The data in Fig. S1B and C represent all genes encoding regulators of inflammation
or immunity-related transcription factors, respectively, with a statistically significant
(P  0.01) 2-fold or greater increase in expression in BMDCs treated with trophic forms
compared to the level in unstimulated BMDCs. While we have previously reported that
trophic forms fail to induce translocation of NF-B in alveolar macrophages and that
trophic forms suppress the production of IL-1, IL-6, and TNF- protein by dendritic
cells, these data indicate that dendritic cells are responsive to the trophic forms (11, 12).
Furthermore, treatment of dendritic cells with trophic forms induces a pattern of gene
expression distinct from that of stimulation with curdlan and mixed P. murina organ-
isms.
Stimulation with trophic forms leads to attenuated expression of multiple
cytokine genes compared to treatment with a mixture of trophic forms and cysts.
We previously published that Pneumocystis trophic forms suppressed the production of
proinflammatory cytokines IL-1, IL-6, and TNF- by dendritic cells stimulated with
multiple PAMPs (11). A principle aim of the gene expression array was to identify the
extent of the suppressive impact of trophic forms on dendritic cells. Data shown in Fig.
2A represent relative gene expression at 8 h poststimulation of every cytokine included
in the preassembled panel. Gene expression is displayed as the log2 value of the
quotient of the value in treated cells divided by that in untreated cells. Stimulation with
trophic forms led to the expression of the vast majority of the cytokine genes included
in the panel. However, the magnitude of this upregulation was attenuated compared
to treatment with mixed P. murina organisms or curdlan. For example, treatment with
trophic forms increased the expression of transcripts encoding IL-1 and IL-6. However,
this upregulation was not as great as that observed in cells stimulated with mixed P.
murina organisms or curdlan (Fig. 2A). In addition, IL-1 and IL-6 proteins were not
detectable in the supernatant of dendritic cells stimulated with purified trophic forms
(Fig. S2). Treatment with trophic forms failed to induce gene and protein expression of
TNF- (Fig. 2A and S2). Mixed P. murina organisms and curdlan both induced expres-
sion of the transcript encoding TNF-. However, as previously reported, stimulation
with curdlan but not mixed P. murina organisms induced protein expression of TNF-
(11).
Trophic forms induce less robust expression of multiple transcription factors
and positive regulators of inflammation than treatment with a mixture of trophic
forms and cysts. Data shown in Fig. 2B represent genes that encode positive regula-
tors of inflammation whose expression was significantly different (greater than 2-fold
difference; P  0.01) between the cells treated with trophic forms and those treated
with mixed P. murina organisms at 8 h. Notably, treatment with trophic forms in the
absence of cysts led to less robust expression of a wide range of mediators of
inflammation, including the genes encoding the dendritic cell maturation marker
SLAMF1, than stimulation with a mixed population of trophic forms and cysts. Data
shown in Fig. 2C represent genes that encode immunity-associated transcription
Evans et al. Infection and Immunity
October 2017 Volume 85 Issue 10 e00396-17 iai.asm.org 4
 on A
ugust 2, 2018 by guest
http://iai.asm
.org/
D
ow
nloaded from
 
factors whose expression was significantly different (greater than 2-fold difference; P 
0.01) between the cells treated with trophic forms and those treated with mixed P.
murina organisms at 8 h. Conventional dendritic cells (cDCs) may be divided into two
broad subsets: CD8 CD103 cDC1s, which promote Th1 polarization, and CD11b
cDC2s, which promote Th2 or Th17-type responses (13–18). Treatment with trophic
forms reduced the expression of the transcripts encoding the cDC1-associated tran-
scription factors Batf3 and Irf8 and the expression of the cDC2-associated transcription
factor Irf4 below the basal level of expression. In contrast, stimulation with mixed P.
murina organisms enhances the expression of each of these markers.
Suppression of the cytokine response is not dependent on trophic form via-
bility but is partially dependent on direct contact between trophic forms and
dendritic cells. Pneumocystis trophic forms suppress the production of proinflamma-
tory cytokines IL-1, IL-6, and TNF- by dendritic cells stimulated with multiple PAMPs
(Fig. S2) (11). We report here that trophic forms are capable of suppressing the
expression of multiple immunity-related genes (Fig. 1 and 2) below the basal level of
expression. To determine if suppression requires live participation by the trophic forms,
FIG 2 Trophic forms induce less robust expression of multiple cytokines, positive regulators of inflamma-
tion, and transcription factors than treatment with a mixture of trophic forms and cysts. The relative gene
expression level after 8 h of treatment was calculated as the log2 value of the quotient of the expression
value in treated cells divided by that of untreated cells. All cytokine genes in the preassembled NanoString
panel are graphed (A). The data in panels B and C represent all genes encoding regulators of inflammation
or immunity-related transcription factors with a statistically significant 2-fold or greater difference in
expression between BMDCs treated with trophic forms versus those treated mixed P. murina organisms.
Differences in expression levels between the groups were identified by log-transformed two-way ANOVA,
followed by pairwise comparisons using the least significant difference method. Five biological replicates
were used per group. A change was deemed significant if the P value was 0.01. Significant differences
(P  0.01) between results are indicated as follows: *, between BMDCs treated with trophic forms and
unstimulated cells; †, between cells treated with trophic forms and those treated with mixed P. murina
organisms; ‡, between cells treated with trophic forms and those treated with curdlan.
Dendritic Cell Suppression by P. murina Trophic Forms Infection and Immunity
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we tested the ability of heat-killed (Fig. 3A to C) or sonicated (Fig. 3D to F) trophic forms
to prevent IL-1, IL-6, and TNF- cytokine production in BMDCs treated with curdlan.
Live, heat-killed, and sonicated trophic forms suppressed cytokine production, indicat-
ing that trophic-form-mediated suppression is not dependent on the viability of trophic
forms. Surprisingly, while intact mixed P. murina organisms induce IL-1 and IL-6
production, these data indicate that sonicated mixed P. murina organisms suppressed
these responses. These data suggest that intact cysts are required for stimulation of
cytokine production, and, in the absence of this stimulation, that the trophic material
is able to suppress the response to other PAMPs.
Immunosuppression by the trophic forms could be mediated by a secreted factor or
by direct contact between the trophic forms and the BMDCs. We measured curdlan-
induced IL-1, IL-6, and TNF- cytokine production by BMDCs separate from trophic
forms by Transwell polyester inserts with 0.4-m pores (Fig. 3G to I). Direct contact
between the trophic forms and BMDCs was not required for a reduction in IL-1 or
FIG 3 Suppression of the cytokine response is not dependent on trophic form viability but is partially dependent on direct contact
between trophic forms and dendritic cells. A total of 1  104 BMDCs (A to F) from BALB/cJ mice were incubated with 5  105 trophic
forms, 5  105 heat-killed trophic forms, 5  105 sonicated trophic forms, 5  105 sonicated mixed P. murina organisms, and/or 10
g/ml curdlan for 72 h. A total of 1  105 BMDCs (G to I) from BALB/cJ mice were incubated with 5  106 trophic forms and/or 10
g/ml curdlan for 72 h in a Transwell culture plate. TNF-, IL-1, and IL-6 cytokine production, as indicated, was quantified by ELISA.
Data represent the means  standard deviations of three biological replicates per group and are representative of two separate
experiments. One-way ANOVA with Student-Newman-Keuls post hoc tests was used to compare differences among the groups where
the data were parametric (A to D and G to I): *, P  0.05; **, P  0.01; ***, P  0.001; n.s., not statistically significant. Kruskal-Wallis
one-way ANOVA on ranks was used to compare differences among the groups where the data were nonparametric (E to F): *,
P  0.05.
Evans et al. Infection and Immunity
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TNF- cytokine production (Fig. 3G and H). Intriguingly, direct contact was required for
the suppression of IL-6 protein production (Fig. 3I).
A relatively small amount of P. murina DNA was detected in the lower Transwell
compartment, and quantitative PCR indicated that up to 2  103 trophic forms (or
equivalent trophic DNA) may have crossed the Transwell membrane (data not shown).
However, the addition of greater than 106 trophic forms was required to see the level
of suppression that was observed in the Transwell system (Fig. S3). In addition, a
portion of the supernatant from the lower compartments was cytospun onto slides and
examined under a microscope (limit of detection, 102 organisms) (data not shown). No
trophic forms were observed, further confirming that a significant proportion of the
trophic forms did not cross the membrane. These controls indicate that the suppression
of TNF- and IL-1 shown by the data in Fig. 3G to I was due to material secreted or
shed from trophic forms rather than from the passage of whole trophic forms through
the Transwell membrane.
Trophic forms suppress the expression of multiple factors related to antigen
presentation, including MHC class II and the costimulatory molecule CD40. We
have previously reported that infection of wild-type mice with trophic forms induces
less expression of MHC class II on the surface of CD11c CD11b and CD11c CD11b
cells within the lungs than infection with mixed P. murina organisms (11). This finding
correlated with less robust CD4 T cell recruitment and proliferation in the lungs of
mice infected with trophic forms than in mice infected with mixed P. murina organisms
(11). The preassembled NanoString panel included several genes related to antigen
presentation (Fig. 4A). These data indicate that trophic forms suppress the expression
of multiple antigen presentation genes below the basal level of expression. Ciita
encodes the class II transactivator, a master regulator of genes related to MHC class II
expression. The expression of Ciita is 10-fold lower in BMDCs treated with trophic forms
than in the unstimulated control (Fig. 4A). In contrast, stimulation with mixed P. murina
organisms led to a 3-fold decrease in Ciita expression compared to the level in the
unstimulated control, while treatment with curdlan did not significantly alter the
expression of Ciita (Fig. 4A). Data shown in Fig. 4B represent the relative expression
levels of genes encoding costimulatory molecules. Treatment of BMDCs with trophic
forms induces lower levels of expression of the transcripts encoding the costimulatory
molecules CD40, CD80, CD86, PD-L1, and PD-L2 than stimulation with mixed P. murina
organisms.
Flow cytometry was used to evaluate protein expression of MHC class II (Fig. 4C and
E) and CD40 (Fig. 4D and F) on the surface of BMDCs treated for 24 h with trophic forms,
mixed P. murina organisms, and/or zymosan. Zymosan is a protein-carbohydrate prep-
aration from the cell wall of Saccharomyces cerevisiae, and, unlike curdlan, zymosan may
be processed and presented as protein antigen. Treatment of BMDCs with trophic
forms resulted in reduced surface expression of MHC class II and CD40 compared to
that after treatment with mixed P. murina organisms and/or zymosan. Addition of
trophic forms to BMDCs treated with P. murina organisms or zymosan inhibited the
expression of MHC class II and CD40 (Fig. 4E and F). These data indicate that trophic
forms suppress the expression of MHC class II and the costimulatory molecule CD40 on
the surface of dendritic cells. Maturation of dendritic cells is characterized by an initial
burst in antigen presentation and MHC class II expression, followed by a reduction in
additional antigen processing and presentation. However, surface expression of
peptide-MHC class II complexes is highly stable in mature dendritic cells, with a
reported half-life of 31 h observed in dendritic cells stimulated with LPS (19). Therefore,
the observed reduction in MHC class II surface expression after 24 h of stimulation
suggests that treatment with trophic forms impedes the maturation of dendritic cells.
Pretreatment of dendritic cells with trophic forms reduces allogeneic CD4 T
cell proliferation in a mixed lymphocyte reaction. In order to determine the signif-
icance of reduced MHC class II on BMDCs treated with trophic forms, a mixed-
lymphocyte reaction was used in which T cell proliferation is dependent on detection
of allogeneic MHC class II but not specific antigen. To test the effect of trophic forms
Dendritic Cell Suppression by P. murina Trophic Forms Infection and Immunity
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on allogeneic CD4 T cell proliferation, BMDCs generated from IAd-expressing BALB/cJ
mice were pretreated with trophic forms or mixed P. murina organisms for 1 h (Fig. 5A).
Carboxyfluorescein succinimidyl ester (CFSE)-stained splenocytes from uninfected IAb-
expressing C57BL/6 mice were then added to the wells and cocultured for 6 days. Flow
cytometry was used to evaluate the proliferation of C57BL/6 CD4 T cells (Fig. 5A).
Pretreatment of allogeneic BMDCs with trophic forms, but not with mixed P. murina
organisms, reduced CD4 T cell proliferation and IFN- production in the mixed-
lymphocyte reaction (Fig. 5A). These data are consistent with trophic forms suppressing
MHC class II expression, resulting in the inability of the pretreated dendritic cells to
FIG 4 Trophic forms suppress the expression of multiple factors related to antigen presentation, including MHC
class II and the costimulatory molecule CD40. The data in panels A and B represent genes in the NanoString panel
encoding transcripts related to antigen-processing and presentation (A) or costimulatory molecules (B) with a
statistically significant (P  0.01) 2-fold or greater increase in expression in BMDCs treated with trophic forms
compared to levels in unstimulated BMDCs. The relative gene expression after 8 h of treatment was calculated as
the log2 value of the quotient of the expression value of treated cells divided by that of the untreated cells.
Significant differences (P  0.01) between results are indicated as follows: *, between BMDCs treated with trophic
forms and unstimulated cells; †, between cells treated with trophic forms and cells treated with mixed P. murina
organisms; ‡, between cells treated with trophic forms and those treated with curdlan. Flow cytometry was used
to evaluate surface expression of MHC class II (C and E) and CD40 (D and F) on the surface of BMDCs following 24
h of treatment with trophic forms, mixed P. murina organisms, and/or the fungal cell wall preparation zymosan.
Flow cytometry data represent the means  standard deviations of three biological replicates per group and are
representative of two separate experiments. One-way ANOVA with Student-Newman-Keuls post hoc tests was used
to compare the surface expression of MHC class II or CD40 protein among the groups: *, P  0.05; **, P  0.01; ***,
P  0.001.
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stimulate antigen-independent allogeneic T cell proliferation in a mixed-lymphocyte
reaction.
Trophic form-loaded dendritic cells stimulate less-robust CD4 T cell re-
sponses. CD4 T cell responses are required for the clearance of P. murina (2). We have
previously reported that BMDCs loaded with mixed P. murina organisms, but not
trophic forms, stimulate IFN- production by CD4 T cells in vitro (11). To evaluate
whether dendritic cells are able to present antigen and induce CD4 T cell responses
when loaded with trophic forms, we broadened our analysis to include proliferation
FIG 5 Trophic forms reduce dendritic cell-dependent proliferation of CD4 T cells. Treatment with trophic forms
reduces CD4 T cell proliferation in response to coculture with allogeneic BMDCs in a mixed-lymphocyte reaction.
(A) BMDCs generated from BALB/cJ mice were pretreated with trophic forms or mixed P. murina organisms for 1 h.
CFSE-stained splenocytes from uninfected C57BL/6 mice were then added to the wells and cocultured for 6 days. Flow
cytometry was used to identify the CD4 T cells and evaluate their proliferation. (B to E) BMDCs stimulated with trophic
forms induce less proliferation and cytokine protein expression in CD4 T cells than cells stimulated with mixed
P. murina organisms. BMDCs and CFSE-stained CD4 T cells from adult BALB/cJ mice were incubated with trophic
forms or mixed P. murina organisms for 6 days. Flow cytometry was used to evaluate proliferation of CD4 T cells
(B). ELISA was used to evaluate the concentrations of the cytokines IFN- (A and C), IL-13 (D), and IL-17A (E) in the
supernatant. Data represent the means  standard deviations of three biological replicates per group and are
representative of at least two separate experiments. One-way ANOVA with Student-Newman-Keuls post hoc test
was used to compare the percentage of proliferating CD4 T cells or supernatant cytokine concentration among
the groups: *, P  0.05; **, P  0.01; ***, P  0.001; n.s., not statistically significant.
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and other T helper cytokines (Fig. 5B to E). BMDCs loaded with mixed P. murina
organisms, but not trophic forms, stimulated proliferation in CFSE-labeled CD4 T cells
(Fig. 5B). To confirm that trophic forms are phagocytosed by BMDCs, confocal micros-
copy was used to demonstrate that 9-H-(1,3-dichloro-9,9-dimethylacridin-2-one-7-yl)-
succinimidyl ester (DDAO-SE)-labeled trophic forms were internalized (Fig. S4A). Fur-
thermore, confocal microscopy (Fig. S4B and C) and flow cytometry (Fig. S4D and E)
confirmed that stimulation of dendritic cells with trophic forms does not reduce the
ability of dendritic cells to phagocytose pHrodo green-labeled zymosan bioparticles,
which fluoresce under low pH conditions.
BMDCs loaded with mixed P. murina organisms stimulated higher production of the
Th1-type cytokine IFN-, the Th2-type cytokine IL-13, and the Th17-type cytokine IL-17A
by CD4 T cells than stimulation with trophic forms alone (Fig. 5C to E). However,
stimulation with trophic forms did induce greater production of IL-13 than that of the
unstimulated control (Fig. 5D). These data indicate that while cysts are required for
robust proliferation of CD4 T cells and production of cytokines in vitro, BMDCs loaded
with trophic forms are capable of driving modest Th2-type T cell polarization. P. murina
organisms did not stimulate CD4 T cell proliferation and cytokine production in the
absence of BMDCs, indicating that these responses are dependent on antigen presen-
tation by BMDCs (data not shown).
DISCUSSION
We have previously reported that the cyst life cycle stage drives proinflammatory
responses that direct the early recruitment of innate and adaptive immune cells.
Infection of adult mice with Pneumocystis trophic forms in the absence of cysts leads to
the establishment of an immunosuppressive environment in the lungs that persists for
up to 1 week following the formation of the cystic stage (11). If cysts are in the
inoculum, the trophic form is unable to suppress inflammatory responses in the lungs
as effectively. We have reported that the trophic life cycle forms dampen -glucan and
Toll-like receptor (TLR)-induced inflammation compared to the level after stimulation
with a mixture of trophic forms and cysts (11). Here, our data confirm that P. murina
trophic forms hinder the ability of dendritic cells to serve in their essential role as
stimulators of CD4 T cell responses by reducing the capacity of dendritic cells to
produce proinflammatory cytokines, present MHC class II, and express costimulatory
molecules.
We did not define the factor(s) expressed by the trophic forms that induces
suppression. However, experiments were presented that have begun to define the
nature of these factors. Intriguingly, suppression of the dendritic cell cytokine response
was not dependent on trophic form viability and was only partially dependent on direct
contact between trophic forms and dendritic cells. Not much is known about secreted
proteins from Pneumocystis organisms, but it has been shown that the organisms can
form a biofilm-like substance consisting of a conglomeration of carbohydrates and
glycosylated proteins, including glycoprotein A (gpA; or major surface glycoprotein,
MSG), presumably shed from the cell surface (6). It is plausible that either secreted
proteins or shed glycosylated proteins such as gpA are responsible for trophic form-
mediated suppression. This is an area of great interest and focus in our laboratory.
Dendritic cell activation is dependent on the expression of a wide range of tran-
scription factors and signaling mediators related to inflammatory responses. Here, we
report that trophic forms induced a differential pattern of gene expression in dendritic
cells compared to that following treatment with a normal mixture of trophic forms and
cysts. Treatment of dendritic cells with trophic forms induced a less robust pattern of
expression of several immunity-related genes than treatment with a mixture of P.
murina trophic forms and cysts. We previously published that Pneumocystis trophic
forms suppressed the production of proinflammatory cytokines IL-1, IL-6, and TNF-
by dendritic cells stimulated with multiple PAMPs, including -glucan, LPS, LTA, zymo-
san, and depleted zymosan (11). Here, we demonstrate that transcript levels of these
proinflammatory cytokines are lower in dendritic cells treated with trophic forms than
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in those treated with mixed P. murina organisms. These data suggest that the cyst life
cycle is required for robust cytokine production by dendritic cells.
Trophic forms induce differential regulation of several genes related to inflammation
and transcription compared to levels with stimulation with mixed P. murina organisms.
These genes encompass diverse signaling pathways, including genes encoding mem-
bers of the interferon regulatory factor (IRF) and STAT families. Here, we show that
treatment with trophic forms suppressed the expression of Batf3 and Irf8, which
mediate the development of Th1-promoting CD8 CD103 conventional DCs (cDC1s).
The expression of Irf4, which mediates the development of Th2/Th17-promoting
CD11b cDCs (cDC2s) was also suppressed by treatment with trophic forms but
induced by treatment with mixed P. murina organisms. These data suggest that trophic
forms may broadly suppress the development of multiple dendritic cell subsets and are
consistent with the failure of trophic form-stimulated dendritic cells to induce robust
production of T helper cytokines compared to that following stimulation with mixed P.
murina organisms. It should be noted, however, that the BMDCs employed in these
experiments more closely resemble monocyte-derived dendritic cells and are not true
conventional dendritic cells, which require Flt3L for differentiation (20, 21). The ability
of trophic forms to suppress Batf3, Irf8, and Irf4 expression in Flt3L-dependent con-
ventional dendritic cells has not been evaluated.
Some fungal pathogens, including Candida spp. and Histoplasma capsulatum, may
prevent phagosomal maturation and acidification (22–24). However, our data indicate
that stimulation with trophic forms or mixed P. murina organisms does not reduce the
phagocytic capacity of the dendritic cell. Rather, our data confirm that treatment with
trophic forms reduces the ability of dendritic cells to present antigen. Treatment with
trophic forms reduced the ability of dendritic cells to increase surface expression of
MHC class II and CD40 in response to stimulation with mixed P. murina organisms or
zymosan (a Saccharomyces cell wall preparation). Our data indicate that this suppres-
sion occurred at the level of transcription as treatment with trophic forms led to
downregulation of several genes associated with MHC class II processing and expres-
sion, including the gene encoding the master class II transactivator, CIITA. Treatment
with trophic forms also resulted in lower expression of the genes encoding the
costimulatory molecules CD40, CD80, and CD86, as well as the immune regulatory
molecules PD-L1, and PD-L2, than treatment with a mixture of organisms that con-
tained cysts. These defects in the expression of MHC class II and costimulatory mole-
cules corresponded with a reduced capacity for trophic form-loaded dendritic cells to
stimulate CD4 T cell proliferation and polarization.
Modulation of the T helper phenotype of the inflammatory response is a common
strategy employed by infectious fungi for immune evasion (25, 26). However, while Th1
or Th17 responses are critical for control of many fungal infections, a mixed T helper
response is observed in response to Pneumocystis infection. This mixed response
appears to be largely redundant as Th1-, Th2-, and Th17-type responses have each been
associated with clearance of P. murina organisms (27–32). Broad suppression of cyto-
kine production by trophic forms may be necessary to overcome this redundancy and
delay the activation of adaptive immunity against P. murina.
Here, the data indicate that dendritic cells loaded with trophic forms stimulate
production of the Th2-type cytokine IL-13 but not production of the Th1-type cytokine
IFN- or the Th17-type cytokine IL-17A. These data indicate that trophic forms may
polarize the immune response toward a weak Th2-type response. However, the effec-
tiveness of this response in the absence of CD4 T cell proliferation is unclear. In
addition, it is unclear how trophic forms, which suppress IL-6 protein production (11)
and fail to induce expression of the genes encoding IL-2, IL-4, and IL-13 as robustly as
stimulation with mixed P. murina organisms, promote Th2 polarization. The CD4 T
cells used in this experiment were generated from the draining lymph nodes of donor
mice infected with mixed P. murina organisms. We expect that this population included
P. murina-specific Th2 CD4 T cells (29, 31), which may have continued to produce IL-13
but not proliferate in the presence of trophic form-loaded dendritic cells. The failure of
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trophic forms to induce Th1 and Th17 CD4 T cell polarization is consistent with the
attenuated expression of the genes encoding IL-1, IL-2, IL-6, and IL-12 compared to
that with stimulation with mixed P. murina organisms.
In addition, trophic forms induce the expression of the genes that encode the
transcription factors T-bet (Tbx21) and Gata3 (see Fig. S1C in the supplemental mate-
rial), which mediate Th1 and Th2-type responses, respectively. T-bet expression in
dendritic cells is required for effective polarization of Th1 T cells (33–35). GATA3
expression in BMDCs is required for production of the Th2-type cytokines IL-13 and IL-5
(36). This indicates that the failure of trophic forms to induce robust Th1 and Th2
responses is not due to direct suppression of the transcription of these master regu-
lators.
Tolerogenic dendritic cells promote anergic or regulatory T cell responses by
secreting IL-10, transforming growth factor  (TGF-), and IL-2 and by expressing the
inhibitory molecules PD-L1 and PD-L2. However, our data indicate that treatment of
dendritic cells with trophic forms results in lower levels of gene expression of each of
these tolerogenic markers than those produced by treatment with a mixture of trophic
forms and cysts. Therefore, trophic forms are not likely to induce a classical tolerogenic
phenotype in dendritic cells. Rather, our data indicate that treatment with trophic forms
broadly reduces the ability of the dendritic cell to provide activation signals to the
CD4 T cells.
The inflammatory potential of the cysts in the face of a 10-fold excess of suppressive
trophic forms should not be understated. The ability of trophic forms to suppress
cytokine production is dose dependent, and our data suggest that slight changes in the
ratio of trophic forms to cysts may shift the balance between suppression and stimu-
lation (11). Increasing the trophic form-to-cyst ratio from 10:1 to 12:1 (by the addition
of 105 trophic forms) is sufficient for the trophic forms to begin to reduce the IL-6
response to the mixed population (11). Cysts are the transmittable life cycle stage
during natural infection. Our in vivo data indicate that the cyst burden remains low
during the first week postinfection but that cysts in the inoculum drive the initial
inflammation (11). Therefore, the rapid establishment of an immunosuppressive trophic
population may be critical to avoid preemptive detection and clearance in immuno-
competent hosts. Conversely, immunocompromised mice with severe pneumonia
experience a final burst of trophic growth in which the ratio of trophic forms to cysts
reaches as high as 30:1 (unpublished observation). This population shift may prolong
the life of the immunocompromised host by dampening inflammation and may extend
the window of opportunity for the transmission of cysts to additional hosts.
In summary, our data indicate that the trophic life cycle stage of Pneumocystis limits
the ability of dendritic cells to stimulate CD4 T cell polarization and proliferation by
reducing the expression of MHC class II, costimulatory molecules, and proinflammatory
cytokines. These defects may be traced back to reduced levels of gene expression of
each of these factors compared to levels in dendritic cells stimulated with a physio-
logically normal mixture of trophic forms and cysts. We propose that the suppression
of immune responses by the trophic forms promotes the colonization of Pneumocystis
in immunocompetent hosts. This differential immune response to Pneumocystis trophic
forms and cysts is most certainly a leading contributor to the success of the organisms
as human pathogens.
MATERIALS AND METHODS
Mice. Six-week-old female BALB/cJ and C57BL/6 mice were purchased from the Jackson Laboratory
and infected at 8 weeks of age for either the adult experiments or to generate CD4 T cells for the in
vitro experiments. Uninfected adult female BALB/cJ and C57BL/6 mice from the Jackson Laboratory were
used to generate BMDCs for the in vitro experiments. Mice were maintained at the University of Kentucky
Department of Laboratory Animal Resources (DLAR) under specific-pathogen-free conditions.
C.129S6(B6)-Rag2tm1Fwa N12 (Rag2/) mice, originally from Taconic (Germantown, NY), were used to
maintain a source of P. murina and were bred at DLAR in sterile microisolator cages with sterilized food
and water. The University of Kentucky Institutional Animal Care and Use Committee approved all
protocols regarding animal use.
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P. murina isolation and infection. Lungs were excised from P. murina-infected Rag2/ mice and
pushed through stainless steel mesh in Hanks’ balanced salt solution (HBSS) containing 0.5% glutathione
at pH 7.3, as previously described (11). Cell debris was broken up by aspiration through 20- and 26-gauge
needles and then removed by centrifugation at 100  g for 3 min. Trophic forms were isolated by
removing the supernatant following centrifugation at 400  g for 7 min. This preparation results in
greater than 99% pure trophic forms (11). The pellet from the spin at 400  g contained a mixed
population of cysts and trophic forms at a typical ratio of 10:1 trophic forms to cysts. Erythrocytes in the
pellet were lysed with water, and organisms were suspended in an equal volume of 2 phosphate-
buffered saline (PBS). Organisms were incubated with 200 U of DNase (Sigma-Aldrich, St. Louis, MO) at
37°C for 30 min. Clumps were broken up by aspiration through a 26-gauge needle. The remaining cell
debris was removed by centrifugation at 100  g for 3 min, followed by passage over a 70-m-pore-size
filter. Aliquots of mixed P. murina organisms or purified trophic forms were diluted, and 100-l aliquots
were spun onto a 28.3-mm2 area of glass slides. Slides were fixed in methanol and stained with DiffQuik
(Siemens Healthcare Diagnostics, Inc., Deerfield, IL). Organism numbers were determined microscopically
using a 100 oil immersion objective of a Nikon microscope.
Generation of murine cells for in vitro assays. BMDCs were generated from uninfected BALB/cJ
and C57BL/6 adult female mice, as previously described (11). Briefly, BMDCs were produced by flushing
cells from the bone marrow of the tibias and femurs of female adult mice with PBS plus 5% heat-
inactivated fetal bovine serum (FBS). Erythrocytes were removed using ammonium chloride-potassium
(ACK) lysing buffer (37). Cells were washed and resuspended in culture medium containing RPMI medium
with 10% heat-inactivated FBS, 0.5 mM 2-mercaptoethanol, 1% minimal essential medium (MEM) with
nonessential amino acids, 100 units/ml penicillin, 100 g/ml streptomycin, and 50 g/ml gentamicin.
Cells were plated in 100-mm petri dishes at a cell density of 4  106 in 10 ml of culture medium with
20 ng/ml recombinant murine granulocyte-macrophage colony-stimulating factor (GM-CSF) (Peprotech,
Rocky Hill, NJ). Plates were cultured at 37°C in 5.0% CO2. An additional 10 ml of culture medium with 20
ng/ml recombinant murine GM-CSF was added to cells after 24 h of growth. Every 48 h thereafter,
nonadherent cells were removed and replaced with 10 ml of fresh medium containing recombinant
murine GM-CSF. Cells were cultured for 9 to 12 days. BMDCs were collected by vigorously washing plates
with medium to remove loosely adherent cells. BMDCs were washed, resuspended, and split for
phenotyping or cytokine assay. Greater than 80% of recovered cells were CD11c.
CD4 T cells were generated by infecting adult BALB/cJ mice with 107 mixed P. murina organisms as
described previously. Tracheobronchial lymph nodes (TBLN) were excised 10 to 14 days postinfection
and pushed through 70-m-pore-size nylon mesh screens in HBSS. Erythrocytes were removed using
ACK. Cells were washed and counted. CD4 (L3T4) microbeads were used for positive selection of CD4
cells (Miltenyi Biotec, San Diego, CA). Greater than 90% of recovered cells were CD4 T cells. Splenocytes
for the mixed lymphocyte reaction were collected from uninfected adult C57BL/6 mice. Spleens were
excised and pushed through 70-m-pore-size nylon mesh screens in HBSS. Erythrocytes were removed
using ACK. Cells were washed and counted.
NanoString gene expression assay. A total of 3  104 BMDCs in 96-well Stripwell plates were
stimulated with 10 g/ml curdlan (-1,3-glucan from Alcaligenes faecalis), 1.5  106 trophic forms, or
1.5  106 mixed P. murina organisms at 37°C in 5.0% CO2 for 2, 4, and 8 h in BMDC culture medium.
Additional controls, including BMDCs treated with curdlan and trophic forms, were allowed to incubate
for 72 h. The control supernatants were screened for IL-1, IL-6, and TNF- cytokine production by
enzyme-linked immunosorbent assay (ELISA) (eBioscience, San Diego CA).
At the conclusion of the 2-, 4-, and 8-h time points, the appropriate Stripwell segments were removed
from the plate structure. Strips were washed once with PBS. Cells were lysed in TriReagent, and RNA was
extracted with a Direct-zol RNA MiniPrep kit (Zymo Research, Irvine CA). The Direct-zol RNA MiniPrep kit
permitted optimal hybridization of samples to the NanoString probes, presumably due to reduced
contamination of chaotropic salts compared to that with other RNA extraction protocols.
Quality of the RNA was confirmed with a 2100 Bioanalyzer instrument (Agilent Technologies, Santa
Clara, CA). More than 50% of the RNA fragments from each sample were larger than 300 bp, satisfying
the quality requirements for NanoString. The RNA integrity number (RIN) for all samples was above 8.0.
A total of 200 ng of each sample was sent to the Microarray Core at the University of Kentucky for
NanoString processing. A NanoString nCounter Mouse Immunology kit (NanoString Technologies,
Seattle, WA) was used to quantify the expression of 561 genes related to the murine immune response.
Briefly, samples were hybridized to a panel of capture probes, and reporter probes were labeled with
fluorescent barcodes. Hybridized samples were immobilized and aligned on the NanoString nCounter
cartridge. Reporter probes were read using the nCounter Analysis System (NanoString Technologies,
Seattle, WA), and counts were tabulated for each target transcript. Raw NanoString data are provided in
Data Set S1 in the supplemental material.
Analysis and normalization of the raw gene expression data were conducted using nSolver Analysis
Software, version 2.0 (NanoString Technologies, Seattle, WA). Raw counts were normalized to those of
the internal positive controls and to those of the following housekeeping genes: Alas1, Eef1g, G6pdx,
Gapdh, Gusb, Hprt, Oaz1, Polr1b, Polr2a, Ppia, Rpl19, Sdha, Tbp, and Tubb5. Heat maps and principal-
component analysis were prepared with the nSolver Analysis Software, version 2.0.
In vitro phagocytosis assays. BMDCs were labeled with 0.5 M CFSE (Tonbo Biosciences, San Diego,
CA) for 10 min at room temperature. Trophic forms and mixed P. murina organisms were labeled with
1 M CellTrace Far Red DDAO-SE at 37°C for 7 min. A total of 105 CFSE-labeled BMDCs were preincubated
in chamber slides for 1 h at 37°C in 5.0% CO2 in BMDC culture medium. A total of 2  105 DDAO-SE-
labeled trophic forms or 2  105 DDAO-SE-labeled mixed P. murina organisms were incubated with the
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BMDCs for 60 min. Samples were washed three times in PBS, followed by fixation in 10% neutral buffered
formalin for 10 min. Slides were washed in PBS, and coverslips were mounted with Prolong Gold. Slides
were cured for 48 h at room temperature. Slides were examined using a Nikon A1RSi microscope and
NIS-Elements software. A minimum of 100 cells were analyzed per group.
A total of 105 BMDCs were incubated in round-bottom polystyrene tubes or on chamber slides for
1 h at 37°C in 5.0% CO2 in BMDC culture medium. A total of 2  105 DDAO-SE-labeled trophic forms,
2  105 DDAO-SE-labeled mixed P. murina organisms, and/or 100 g/ml pHrodo green-labeled zymosan
bioparticles (ThermoFisher Scientific, Waltham, MA) were incubated with the BMDCs for 60 min. Samples
were washed three times in PBS. For confocal microscopy, chamber slides were fixed in 10% neutral
buffered formalin for 10 min at room temperature. Slides were washed in PBS and treated with 300 nM
4=,6=-diamidino-2-phenylindole (DAPI) for 30 min. Slides were washed in PBS, and coverslips were
mounted with Prolong Gold. Slides were cured for 48 h at room temperature. Slides were examined using
a Nikon A1RSi microscope and NIS-Elements software. A minimum of 100 cells were analyzed per group.
For flow cytometry, samples in round-bottom polystyrene tubes were washed twice in cold PBS. Samples
were resuspended in 300 l of cold HBSS. The phagocytic capacity of the cells was determined by flow
cytometry using an LSRII flow cytometer (BD Biosciences, San Jose, CA). One thousand dendritic cell
events were acquired and analyzed using FlowJo software (TreeStar, Ashland, OR).
In vitro MHC class II and CD40 assays. A total of 105 BMDCs were stimulated with 20 g/ml
zymosan (Saccharomyces cerevisiae cell wall), 106 trophic forms, and/or 106 mixed P. murina organisms
at 37°C in 5.0% CO2 for 24 h in BMDC culture medium. Adherent cells were collected from the plate using
TrypLE expression dissociation reagent. Cells were washed with PBS containing 0.1% bovine serum
albumin and 0.02% NaN3 and stained with appropriate concentrations of fluorochrome-conjugated
antibodies specific for innate immune cells (anti-CD11c clone N418, anti-IAd clone AMS-32.1, and
anti-CD40 clone 3/23). Antibodies were purchased from eBioscience (San Diego, CA) or BD Biosciences
(San Jose, CA). Expression of these molecules on the surface of the cells was determined by multipa-
rameter flow cytometry using an LSRII flow cytometer. One thousand CD11c events were routinely
acquired and analyzed using FlowJo software.
In vitro CD4 T cell proliferation and polarization assays. A total of 105 BMDCs and/or 5  105
CFSE-labeled CD4 T cells were stimulated with 20 g/ml zymosan (Saccharomyces cerevisiae cell wall),
5  105 trophic forms, and/or 5  105 mixed P. murina organisms at 37°C in 5.0% CO2 for 6 days in BMDC
culture medium. For the mixed-lymphocyte reaction, 105 BALB/cJ BMDCs were pretreated with 5  105
trophic forms or mixed P. murina organisms for 1 h at 37°C in 5.0% CO2, followed by the addition of
5  105 CFSE-labeled C57BL/6 splenocytes and further incubation for 6 days. Medium was collected from
the plates and spun at 400  g for 7 min to separate cells from the supernatant. Supernatant was stored
at 80°C for use in IFN-, IL-13, and IL-17A cytokine ELISAs (eBioscience, San Diego CA). Adherent cells
were collected from the plate using TrypLE Express dissociation reagent (ThermoFisher Scientific,
Waltham, MA). Dissociated cells were combined with the cell pellet from the plate medium and washed
in fresh culture medium.
Cells were washed in sterile PBS and stained with Fixable Viability Dye eFluor780 (eBioscience, San
Diego, CA). Cells were washed with PBS containing 0.1% bovine serum albumin and 0.02% NaN3 (PBA)
and stained with peridinin chlorophyll protein (PerCP)-efluor710-conjugated anti-CD4 clone GK1.5. Cells
were washed with PBA and resuspended in 300 l of HBSS. CD4 T cell proliferation was evaluated by
multiparameter flow cytometry using an LSRII flow cytometer (BD Biosciences, San Jose, CA). One
thousand lymphocyte events were routinely acquired and analyzed using FlowJo software (TreeStar,
Ashland, OR).
Transwell contact assay. A total of 1  105 BMDCs, 10 g/ml curdlan, and/or 5  106 trophic forms
were plated in the upper or lower compartments of Transwell plates with a polyester membrane with
0.4-m pores (Corning, Corning, NY). Plates were incubated at 37°C in 5.0% CO2 for 72 h in BMDC culture
medium. Cytokine levels were analyzed as described above. To confirm that trophic forms did not cross
the membrane, samples were cytospun directly onto slides and DiffQuik stained, and 50 fields were
screened.
Additional Transwell replicates were screened for P. murina DNA by quantitative PCR. Briefly, DNA
was isolated from both the top and bottom compartments of the Transwell dishes using a QIAamp
minikit (Qiagen, Hilden, Germany). Presence of trophic DNA was detected using primers designed to
amplify a portion of the 18S rRNA gene of P. murina. Sequences of the primers are the following: forward,
5=-GGGCTTCTTAGAGGGACTGTTGG; reverse, 5=-CGTGCGGCCCAGAACATCTA (IDT, Coralville, IA). The con-
trol plasmid for quantification of P. murina DNA contains the region of the 18S rRNA gene amplified by
these primers (GenScript USA, Inc., Piscataway, NJ). DNA was also isolated from 104, 105, and 106 P.
murina trophic forms. The quantitative PCR amplification was performed with DNA samples in triplicate
for 39 cycles of 95°C for 5 s and 57°C for 30 s using iTaq SYBR green reagent in a C1000 Thermal Cycler
with a CFX96 real-time PCR detection system (Bio-Rad, Hercules, CA). The amount of trophic DNA
calculated to have crossed from the Transwell insert to the bottom chamber would be equivalent to
2  103 organisms. Pneumocystis trophic forms reside in a biofilm-like substance consisting of a
conglomeration of DNA, -glucan, and other sugars (6). It is possible that the trophic DNA detected
across the Transwell represents shed DNA rather than intact organisms.
The number of organisms required to suppress cytokine expression in the Transwell system was
determined by incubating 1  105 BMDCs, 10 g/ml curdlan, and increasing numbers of trophic forms
(ranging from 103 to 106 organisms) in the lower compartments of Transwell plates. Plates were
incubated at 37°C in 5.0% CO2 for 72 h in BMDC culture medium. Cytokine levels were analyzed as
described above.
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Heat-killed trophic forms. Trophic forms were heat-killed by incubation at 56°C for 1 h. Nonviability
of the organisms was confirmed by inoculation into immunocompromised Rag2/ mice. A total of 104
BMDCs were stimulated with 10 g/ml curdlan, 5  105 trophic forms, and/or 5  105 heat-killed trophic
forms at 37°C in 5.0% CO2 for 72 h in BMDC culture medium. IL-1, IL-6, and TNF- cytokine levels were
analyzed as described above.
Statistical analysis. Analysis and normalization of the NanoString data were conducted using
nSolver Analysis Software, version 2.0 (NanoString Technologies, Seattle, WA). Differences among the
groups were identified by log-transformed two-way analysis of variance (ANOVA), followed by pairwise
comparisons using the least significant difference method. Five biological replicates were used per
group. A change was deemed significant if the P value was 0.01.
All other data were analyzed utilizing the SigmaStat statistical software package (SPSS, Inc., Chicago,
IL). Student’s t test or one-way analysis of variance (ANOVA) with Student-Newman-Keuls post hoc tests
was used to determine differences between groups when the data were parametric. Kruskal-Wallis
one-way ANOVA on ranks was used to analyze differences between groups when the data were
nonparametric. Data were determined to be significantly different when the P value was 0.05.
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